Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by April 13, 2026 [2][4]. Group 1: Allegations Against Pomdoctor - The complaint alleges that Pomdoctor and its executives made false and misleading statements and failed to disclose critical information, including involvement in a fraudulent stock promotion scheme and the use of offshore accounts for share dumping [4]. - Specific allegations include the omission of false rumors and artificial trading activity that inflated the stock price, leading to materially misleading statements about the company's business and prospects [4]. Group 2: Stock Performance - Pomdoctor's share price experienced a significant decline from approximately $0.50 per share on December 10, 2025, to about $0.38 per share on December 11, 2025, marking a drop of roughly $0.12 per share or approximately 24% in a single trading session [5]. - This decline was attributed to heightened volatility and selling pressure amid investor concerns regarding the company's financial performance and valuation [5]. Group 3: Legal Proceedings - The role of the lead plaintiff in the class action is to represent the interests of the class members, and any member can apply to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [6]. - Faruqi & Faruqi encourages individuals with information regarding Pomdoctor's conduct to come forward, including whistleblowers and former employees [7].
POM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026